Randomized, Controlled, Parallel, Prospective Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and or Adolescent Subjects, as Applicable, Compared to That of Episodic Treatment

Trial Profile

Randomized, Controlled, Parallel, Prospective Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and or Adolescent Subjects, as Applicable, Compared to That of Episodic Treatment

Completed
Phase of Trial: Phase III/IV

Latest Information Update: 13 Aug 2015

At a glance

  • Drugs Octocog alfa (Primary)
  • Indications Haemophilia A
  • Focus Therapeutic Use
  • Acronyms SPINART
  • Sponsors Bayer
  • Most Recent Events

    • 13 Aug 2015 According to a Bayer media release, 3-year analysis data (patient- and joint-level changes) from this study will be presented at the National Hemophilia Foundation's (NHF) 67th Annual Meeting.
    • 04 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top